Submandibular Gland Sparing Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancers: Xerostomia Outcomes
Journal Title: Indian Journal of Cancer Education and Research - Year 2018, Vol 6, Issue 2
Abstract
Aim: To spare the contralateral submandibular gland in head and neck cancers using IMRT and to compare them with the contralateral unspared group of head and neck cancers also on IMRT but in whom sparing of cSMG is not possible because of various factors and to access xerostomia outcomes in these two groups. Materials and methods: It is a prospective and comparative intent to reduce toxicity levels in 30 patients presented to our hospital of locally advanced head and neck cancers and treated with IMRT and concurrent chemotherapy and their follow-up. All patients with stage I, II / IV Head and Neck cancers to be treated with bilateral head and neck IMRT. Appropriately selected patients with favourable primary tumor characteristics and no definite contralateral neck disease treated with cSMG- sparing. Results: Post treatment after 2 months where a score of 2 was seen in 13.3% of patients in the cSMG sparing was done against 30% of the control group. At the end of 4 and 6 months from commencement of treatment were 3.3% and 3.3% respectively in the study group and,16% and 6.6% in the control group. The difference at 2 and 4 months was clinically significant but statistically could not be proved. This significant difference was observed due to the lower dryness felt by the patients at rest in the cSMG spared arm. Pre irradiation MR sialography with secretion stimulation could not help predict severity of radiation induced xerostomia. Whereas post irradiated MR imaging revealed submandibular gland secretion response in submandibular gland spared arm and revealed that submandibular gland secretion response is most influential to radiation induced xerostomia grading clinically whereas statistical significance could not beproved. This difference was seen when grade 2 and 3 response was seen in base liner SG vs post RT rSG in both IMRT (36% and 30%) and conventional arms (43% and 40%respectively). Conclusions: The useof IMRT with daily imaging and time required for careful selection of patients and properexecution of the treatment may lead to questions regarding the time and the costrequired for execution of this type of planning.
Authors and Affiliations
Madisetty Adilakshmi
Unraveling the Molecular Diversity of Lipid Degrading Enzymes from Microbial Consortia of a Cold Desert from India
Metagenomics has emerged as one of the important tools that can endow bottomless insights about the molecular diversity, distribution, ecological roles, microbial grouping and fastidious biological functions of microorga...
Male Breast Cancer with Skeletal Metastasis: A Case Report and Review of Literature
While it is the most common malignancy in women, breast cancer is rare in men and thus often ignored or overlooked, which leads to delayed diagnosis for the already fulminant condition. Bone is the most common location f...
A Case series of Head and Neck Cancer: A Conversation with Giants and Legends in Oncology
Third International Meeting of Clinical Practice Guidelines in Oncology–2014 and Indian Perspectives was conducted on December 20th 2014. The conference was organized by the unit of medical oncology, Sri Ramachandra Univ...
Vaginal And Bone Metastasis with Retroperitoneal Lymphadenopathy From Renal Cell Carcinoma: A Very Unusual Presentation
At diagnosis approximately 45% of renal cell carcinoma presents with localized disease, 25% with locally advanced disease and 20-30% with metastatic disease. Mostly these tumors metastasize to lung, soft tissue, bone, li...
Weekly Versus Three-Weekly Cisplatin in Concurrent Chemoradiotherapy for Head and Neck Squamous Cancers: A Prospective Study
Concurrent chemoradiotherapy (CT-RT) is often used as definitive treatment for patients with locally advanced head-and-neck squamous cancers (HNSCC). Concurrent cisplatin administered 3- weekly (100 mg/m2 on days 1, 22 a...